A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments With Parkinson Medicinal Products Who Continue to Experience Persistent Motor Fluctuations

The primary objective of this study was to demonstrate the superiority of levodopa - carbidopa intestinal gel over treatment with optimized oral levodopa/carbidopa during 12 weeks.

本研究的核心目标在于验证，在12周疗程中，左旋多巴-卡比多巴肠用凝胶（levodopa-carbidopa intestinal gel）相较于优化口服左旋多巴/卡比多巴治疗的临床优越性。